Petr Kavan
Impact in
Papers in
- Oncology 82
- Colorectal Cancer Treatments and Studies 41
- Cancer Treatment and Pharmacology 22
- Pancreatic and Hepatic Oncology Research 22
- Cancer Immunotherapy and Biomarkers 14
- Co-authors
- Warren Mason (13 shared papers)Olivier Chinot (6 shared papers)Alba A. Brandes (5 shared papers)Wolfgang Wick (6 shared papers)Alain Carpentier (6 shared papers)Timothy F. Cloughesy (5 shared papers)Ryo Nishikawa (6 shared papers)Frank Saran (7 shared papers)
- Journals
- Journal of Clinical Oncology (52 papers)Annals of Oncology (12 papers)Clinical Colorectal Cancer (5 papers)HPB (4 papers)Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (4 papers)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Petr Kavan
134 papers receiving 4.7k citations
Petr Kavan's Hit Papers
Peers
Comparison fields: 5 of 123
- Genetics 1.8k
- Oncology 1.4k
- Internal Medicine 173
- Cancer Research 710
- Hepatology 273
Countries citing papers authored by Petr Kavan
This map shows the geographic impact of Petr Kavan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Kavan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Kavan more than expected).
Fields of papers citing papers by Petr Kavan
This network shows the impact of papers produced by Petr Kavan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Kavan. The network helps show where Petr Kavan may publish in the future.
Co-authors
The 25 scholars most cited alongside Petr Kavan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma Hit paper breakdown → | 2014 | 1851 |
| 2 | 2020 | 276 | |
| 3 | 2010 | 264 | |
| 4 | 2013 | 177 | |
| 5 | 2012 | 163 | |
| 6 | 2014 | 135 | |
| 7 | 2015 | 88 | |
| 8 | 2016 | 79 | |
| 9 | 2018 | 67 | |
| 10 | 2008 | 64 | |
| 11 | 2012 | 62 | |
| 12 | 2017 | 56 | |
| 13 | 2015 | 55 | |
| 14 | 2023 | 54 | |
| 15 | 2018 | 49 | |
| 16 | 2013 | 45 | |
| 17 | 2008 | 43 | |
| 18 | 2023 | 42 | |
| 19 | 2015 | 39 | |
| 20 | 2019 | 37 |
About Petr Kavan
Petr Kavan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Cancer Research and Hepatology, having authored 145 papers that have together received 4.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (41 papers), Glioma Diagnosis and Treatment (24 papers), Cancer Treatment and Pharmacology (22 papers), Pancreatic and Hepatic Oncology Research (22 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Cancer Genomics and Diagnostics (17 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Genetic factors in colorectal cancer (12 papers). The work is most often cited by research in Genetics (1.8k citations), Oncology (1.4k citations), Internal Medicine (173 citations), Cancer Research (710 citations) and Hepatology (273 citations). Petr Kavan has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Warren Mason, Olivier Chinot, Alba A. Brandes, Wolfgang Wick, Alain Carpentier, Timothy F. Cloughesy, Ryo Nishikawa, Frank Saran, Roger Henriksson and Khê Hoang‐Xuan. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Colorectal Cancer, HPB and Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.